Neonatal jaundice is a common symptom in the first 2 weeks after birth, and occurs in 2.4–15% of newborn infants. Most infants with jaundice have unconjugated, indirect hyperbilirubinemia (HB) without any pathological implication. In contrast, cholestatic jaundice with direct hyperbilirubinemia (D‐HB) in infants is regarded as abnormal, and recent guidelines recommend that neonates with jaundice lasting >2–3 weeks of age should be evaluated for D‐HB and, if present, should undergo further evaluation for cholestasis. The main reason for this early evaluation is early detection and prompt Kasai operation for biliary atresia (BA).Biliary atresia is a progressive obstructive disease of the biliary tract, affecting 0.5–2.9 per 10 000 births. Congenital structural anomalies are relatively common in infants with BA: the incidence ranges from 13.4% to 20.3%. Of the congenital anomalies coexisting with BA, congenital heart disease (CHD) is one of the major ones, and is found in 6.3–15% of infants with BA. Therefore, neonates with CHD are thought to be at high risk for BA. The characteristics of cholestatic jaundice or D‐HB, a first clue for the suspicion and diagnosis of BA in infants with CHD, has not been previously reported.Thus, the aim of the study was to clarify the characteristics (i.e. incidence,
Pediatrics International – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
It’s easy to organize your research with our built-in tools.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud